Shenzhen-based Chinese AI drug discovery platform XtalPi has raked in $400 million in a Series D round of financing.
The fresh corpus raised by XtalPi brings its market valuation to over 13 billion yuan ($2 billion).
Shenzhen-based Chinese AI drug discovery platform XtalPi has raked in $400 million in a Series D round of financing.
The fresh corpus raised by XtalPi brings its market valuation to over 13 billion yuan ($2 billion).
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com